Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records
. . Zghebi SS, Steinke DT, Rutter MK, Emsley RA, Ashcroft DM. . Diabetes Obes Metab. 2016 Sep;18(9):916-24. doi: 10.1111/dom.12692. Epub 2016 Jun 30. Abstract AIMS: To examine the risk of major cardiovascular events associated with second-line diabetes therapies, in patients with type 2 diabetes, after adjusting for known cardiovascular risk factors. METHODS: This was …